Robert A Babineau Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 367 Plantation St, Worcester, MA 01605 Phone: 508-334-1443 Fax: 508-334-1448 |
Pamela Tsinteris, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 26 Queen St, Worcester, MA 01610 Phone: 508-860-7706 Fax: 508-796-7014 |
Dalina Hanna, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7 Westport Rd, Worcester, MA 01605 Phone: 508-405-6085 |
Liam Paul Burke, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-2818 Fax: 774-441-7799 |
News Archive
Omega Healthcare Investors, Inc. (NYSE: OHI) today announced that it has entered into a securities purchase agreement with CapitalSource Inc. and several of its affiliates to purchase entities owning 80 long term care facilities ("Facilities") for approximately $565 million. The purchase price includes a purchase option ("Option") to acquire entities owning an additional 63 Facilities for approximately $295 million.
Secretary of State Hillary Rodham Clinton at a meeting of the U.N. Food and Agriculture Organization in Rome said that without immediate action, food shortages and volatile prices could spark global destabilization, the Associated Press reports.
For breast cancer patients who underwent a mastectomy who undergo radiation therapy after immediate breast reconstruction, autologous tissue reconstruction provides fewer long-term complications and better cosmetic results than tissue expander and implant reconstruction, according to a study in the November issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.
UnitedHealth Group today reported first quarter results, highlighted by strong enrollment and revenue growth in each of UnitedHealthcare's benefits businesses and well-diversified revenue growth at Optum. First quarter 2012 net earnings were $1.31 per share, with continued performance on key financial and operational measures.
Life Technologies Corporation today announced that the company has signed an agreement with Quidel Corporation to distribute and commercialize molecular diagnostic assays for the European market.
› Verified 8 days ago